Ophthalmology Market Research
Ophthalmology is the branch of medicine, which deals with the anatomy, physiology and diseases of the eye. Comprehensive research in this field indicates that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis. However, the unmet need in the macular degeneration and macular edema markets make the ophthalmology market attractive in spite of generic erosion. It is believed that the major driving force behind the growth of the market is the rising awareness about the importance of detecting ophthalmic diseases early, the availability of effective diagnostic tools and an increase in the prevalence of diabetes.
Research findings indicate that the global ophthalmology drug and devices market is expected to reach a market size of $36 billion by the year 2014, at a CAGR of 5.4% from 2009-2014. The drugs market is expected to reach a size of $19.8 billion by the year 2014 growing at a CAGR of 4% from 2009-2014.
The Ophthalmology drug therapy market research report provides insight into the pipeline status of ophthalmology therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.
The study basically aims at providing a comprehensive overview of the on-goings of the ophthalmology drugs & therapy market.